Monday, August 25th, 2025
Stock Profile: 3347
3347 Logo

Hangzhou Tigermed Consulting Co., Ltd (3347)

Market: HKEX | Currency: HKD

Address: Shengda Science Park, Building A

Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. It operates through Clinical Trial Solutions; and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides medical imaging, pharmacovigilance, medical Show more




📈 Hangzhou Tigermed Consulting Co., Ltd Historical Chart






📊 Statistics




💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2025 - $0.324500 - 2025-06-12 - Dividend payout
Total Amount for 2025: $0.324500
2024 - $0.623650 - 2024-06-07 - Dividend payout
Total Amount for 2024: $0.623650
2023 - $0.615560 - 2023-05-25 - Dividend payout
Total Amount for 2023: $0.615560
2022 - $0.579615 - 2022-05-24 - Dividend payout
Total Amount for 2022: $0.579615
2021 - $0.361881 - 2021-05-25 - Dividend payout
Total Amount for 2021: $0.361881


📅 Earnings & EPS History for Hangzhou Tigermed Consulting Co., Ltd


DateReported EPS
2024-10-290.37
2024-08-280.3
2024-03-280.17
2023-03-280.47
2022-10-250.48
2022-08-250.57
2022-04-260.44
2021-04-280.52
2021-03-290.49
2020-10-290.39




📰 Related News & Research


🔍 View more Reports